Article
Exploring the Efficacy of a Novel Cannabidiol and Bevacizumab Combination in Non-Small Cell Lung Cancer
2025-11-10
Abstract excerpt
<title>Abstract</title> <p> Background Lung cancer is the leading cause of cancer-related deaths worldwide. Despite advancements in cancer treatment, the survival rate for patients with non-small cell lung cancer (NSCLC) remains around 15%. Therefore, new therapeutic options are needed for treating the patients with NSCLC. Objectives The study's objective was to investigate the effect of the cannabidiol and beva...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8e282c4-1f6d-5b5f-b2da-6cba5ab011f4
- DOI
- 10.21203/rs.3.rs-7737896/v1
